In addition, extensive molecular characterization, including identification of alterations in the PI3K signaling pathway, such as mutations in the PIK3CA gene [78, 79], ensures that the cell lines used in our experiments accurately represent the genetic landscape of BC. This evidence concerns the gene PIK3CB and breast cancer.